Molecular therapies and vaccines face the challenges of emerging infectious diseases
dc.contributor.author | Patel, Ami | |
dc.contributor.author | Weiner, David | |
dc.contributor.author | Xiao, Weidong | |
dc.contributor.author | Baker, Andrew | |
dc.contributor.author | Sanders, Niek | |
dc.contributor.department | Pediatrics, School of Medicine | en_US |
dc.date.accessioned | 2023-06-05T18:45:09Z | |
dc.date.available | 2023-06-05T18:45:09Z | |
dc.date.issued | 2022 | |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Patel A, Weiner D, Xiao W, Baker A, Sanders N. Molecular therapies and vaccines face the challenges of emerging infectious diseases. Mol Ther. 2022;30(5):1789-1790. doi:10.1016/j.ymthe.2022.04.003 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/33505 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.ymthe.2022.04.003 | en_US |
dc.relation.journal | Molecular Therapy | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Emerging communicable diseases | en_US |
dc.subject | Vaccines | en_US |
dc.subject | COVID-19 | en_US |
dc.title | Molecular therapies and vaccines face the challenges of emerging infectious diseases | en_US |
dc.type | Article | en_US |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012659/ | en_US |